Project description:Dexamethasone improves the survival of COVID-19 patients in need of supplemental oxygen therapy. Hospitalized COVID-19 patients eligible for dexamethasone therapy were recruited from the general care ward in several centers in Greece and the Netherlands and whole blood transcriptomic analysis was performed before and after starting dexamethasone treatment. Peripheral blood mononuclear cells (PBMCs) were isolated from healthy individuals and COVID-19 patients and stimulated with inactivated SARS-CoV-2 ex vivo in the presence or absence of dexamethasone and their transcriptome was assessed.

2023-07-26 | GSE227585 | GEO

Glucocorticoid (dexamethasone)-induced metabolome changes in healthy males suggest prediction of response and side effects.

Project description: Not available

| S-EPMC4630650 | biostudies-literature

Harnessing genome-wide association studies to minimize adverse radiation-induced side effects.

Project description: Not available

| S-EPMC7785837 | biostudies-literature

Environmental co-benefits and adverse side-effects of alternative power sector decarbonization strategies.

Project description: Not available

| S-EPMC6864079 | biostudies-literature

Impact of perioperative dexamethasone on postoperative analgesia and side-effects: systematic review and meta-analysis.

Project description: Not available